Efficacy And Safety Of Aclidinium Bromide/formoterol Fumarate Fixed-Dose Combination In Patients With Moderate To Severe COPD, Stratified By COPD Severity

被引：0
|
作者：
D'Urzo, A. [1 ]
Singh, S. D. [2 ]
Kerwin, E. M. [3 ]
Lakkis, H. [4 ]
Chuecos, F. [5 ]
De Miquel, G. [5 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Univ Manchester, Manchester, Lancs, England
[3] Clin Res Inst, Medford, MA USA
[4] Forest Res Inst, Jersey City, NJ USA
[5] AstraZeneca Plc, Barcelona, Spain
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2015年 / 191卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5783
引用
收藏
页数：2
相关论文
共 50 条
  • [41] EFFICACY AND SAFETY OF ONCE-DAILY ACLIDINIUM BROMIDE 200 μG IN COMBINATION WITH FORMOTEROL IN PATIENTS WITH COPD
    Sliwinski, P.
    Perng, D-W
    Chuchalin, A.
    Jones, P. W.
    THORAX, 2010, 65 : A136 - A136
  • [42] Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial
    Tashkin, Donald P.
    Doherty, Dennis E.
    Kerwin, Edward
    Matiz-Bueno, Carlos E.
    Knorr, Barbara
    Shekar, Tulin
    Banerjee, Sibabrata
    Staudinger, Heribert
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2012, 7 : 43 - 55
  • [43] Clinicopharmacological profile of the fixed-dose combination of aclidinium bromide and formoterol fumarate in the management of chronic obstructive pulmonary disease
    Babu, K. Suresh
    Morjaria, Jaymin B.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2015, 9 (02) : 56 - 68
  • [44] Lung function with aclidinium/formoterol fixed-dose combination: Pooled analysis of two phase III studies in COPD
    Singh, Dave
    D'Urzo, Anthony D.
    Donohue, James F.
    Chuecos, Ferran
    Leselbaum, Anne
    Garcia Gil, Esther
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [45] Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT)
    Bateman, Eric D.
    Chapman, Kenneth R.
    Singh, Dave
    D'Urzo, Anthony D.
    Molins, Eduard
    Leselbaum, Anne
    Garcia Gil, Esther
    RESPIRATORY RESEARCH, 2015, 16
  • [46] Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT)
    Eric D. Bateman
    Kenneth R. Chapman
    Dave Singh
    Anthony D. D’Urzo
    Eduard Molins
    Anne Leselbaum
    Esther Garcia Gil
    Respiratory Research, 16
  • [47] Efficacy and Safety of QVA149, a Fixed-Dose Combination of Indacaterol and Glycopyrrolate in Symptomatic Patients With Moderate to Severe COPD: Effect of Gender
    Yadao, Anthony
    Fucile, Sebastian
    Shen, Steven
    Ayers, Tim
    Banerji, Donald
    Fogel, Robert
    CHEST, 2016, 150 (04) : 822A - 822A
  • [48] Analysis Of The Efficacy And Safety Of The Fixed-Dose Combination Of Tiotropium plus Olodaterol In Patients With COPD By Initial Disease Severity
    Korn, S.
    Buhl, R.
    Gronke, L.
    Korducki, L.
    Amatto, V. C.
    Ferguson, G. T.
    Abrahams, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [49] Long-term safety and efficacy of formoterol fumarate inhalation solution in patients with moderate-to-severe COPD
    Hanania, Nicola A.
    Sethi, Sanjay
    Koltun, Arkady
    Ward, Jonathan K.
    Spanton, Jacqui
    Ng, Dik
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 117 - 127
  • [50] INDACATEROL/GLYCOPYRRONIUM BROMIDE FIXED-DOSE COMBINATION FOR THE TREATMENT OF COPD
    Schachter, E. N.
    DRUGS OF TODAY, 2013, 49 (07) : 437 - 446
12345